SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-022992
Filing Date
2021-05-04
Accepted
2021-05-04 07:35:37
Documents
51
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kldo-10q_20210331.htm   iXBRL 10-Q 1190870
2 EX-31.1 kldo-ex311_8.htm EX-31.1 19880
3 EX-31.2 kldo-ex312_6.htm EX-31.2 19814
4 EX-32.1 kldo-ex321_7.htm EX-32.1 13363
  Complete submission text file 0001564590-21-022992.txt   4011730

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA kldo-20210331.xsd EX-101.SCH 30479
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kldo-20210331_cal.xml EX-101.CAL 37861
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kldo-20210331_def.xml EX-101.DEF 70663
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE kldo-20210331_lab.xml EX-101.LAB 247120
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kldo-20210331_pre.xml EX-101.PRE 173779
10 EXTRACTED XBRL INSTANCE DOCUMENT kldo-10q_20210331_htm.xml XML 562573
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Filer) CIK: 0001751299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38822 | Film No.: 21886013
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences